• Journal of Innovative Optical Health Sciences
  • Vol. 8, Issue 1, 1540003 (2015)
Li-Jun Zhang1, Lai-Xing Wang2, Wei-Li Zhang1, Yi-Jia Yan1, and Zhi-Long Chen1、*
Author Affiliations
  • 1Department of Pharmaceutical Science & Technology College of Chemistry and Biology, Donghua University Shanghai 201620, P. R. China
  • 2Changhai Hospital, Second Military Medical University Shanghai 200433, P. R. China
  • show less
    DOI: 10.1142/s1793545815400039 Cite this Article
    Li-Jun Zhang, Lai-Xing Wang, Wei-Li Zhang, Yi-Jia Yan, Zhi-Long Chen. Anti-tumor activities of a novel chlorin derivative for photodynamic therapy in vitro and in vivo[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1540003 Copy Citation Text show less

    Abstract

    In this study, a novel photosensitizer meso-tetra (3-pyrrolidinomethyl-4-methoxyphenyl) chlorin (TPMC) was reported. It displays a characteristic long wavelength absorption peak at 656 nm and it shows a singlet oxygen quantum yield of 0.48. After light irradiation with 650 nm laser, it can kill Eca-109 and SMMC-7721 cells in vitro (25mW/cm2, 1.2 to 3.6 J/cm2) and destroy Eca-109 tumor in nude mice (50mW/cm2, 90 J/cm2). It has the perspective to be developed as a new anti-tumor drug in photodynamic therapy (PDT) photodiagnosis, and deserves further investigation.
    Li-Jun Zhang, Lai-Xing Wang, Wei-Li Zhang, Yi-Jia Yan, Zhi-Long Chen. Anti-tumor activities of a novel chlorin derivative for photodynamic therapy in vitro and in vivo[J]. Journal of Innovative Optical Health Sciences, 2015, 8(1): 1540003
    Download Citation